5-(2-aminopropan-2-yl)-N-[[2-fluoro-4-[2-(1-methylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridin-7-yl]phenyl]methyl]-1,2,4-oxadiazole-3-carboxamide;tert-butyl N-[2-[3-[[2-fluoro-4-[2-(1-methylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridin-7-yl]phenyl]methylcarbamoyl]-1,2,4-oxadiazol-5-yl]propan-2-yl]carbamate
C51H52F2N18O6 — CID 157213156
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-(2-aminopropan-2-yl)-N-[[2-fluoro-4-[2-(1-methylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridin-7-yl]phenyl]methyl]-1,2,4-oxadiazole-3-carboxamide;tert-butyl N-[2-[3-[[2-fluoro-4-[2-(1-methylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridin-7-yl]phenyl]methylcarbamoyl]-1,2,4-oxadiazol-5-yl]propan-2-yl]carbamate
5-(2-aminopropan-2-yl)-N-[[2-fluoro-4-[2-(1-methylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridin-7-yl]phenyl]methyl]-1,2,4-oxadiazole-3-carboxamide;tert-butyl N-[2-[3-[[2-fluoro-4-[2-(1-methylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridin-7-yl]phenyl]methylcarbamoyl]-1,2,4-oxadiazol-5-yl]propan-2-yl]carbamate (PubChem CID 157213156) has the molecular formula C51H52F2N18O6 and a molecular weight of 1051.09 g/mol. Its IUPAC name is 5-(2-aminopropan-2-yl)-N-[[2-fluoro-4-[2-(1-methylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridin-7-yl]phenyl]methyl]-1,2,4-oxadiazole-3-carboxamide;tert-butyl N-[2-[3-[[2-fluoro-4-[2-(1-methylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridin-7-yl]phenyl]methylcarbamoyl]-1,2,4-oxadiazol-5-yl]propan-2-yl]carbamate.
Molecular Properties
| Compound Name | 5-(2-aminopropan-2-yl)-N-[[2-fluoro-4-[2-(1-methylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridin-7-yl]phenyl]methyl]-1,2,4-oxadiazole-3-carboxamide;tert-butyl N-[2-[3-[[2-fluoro-4-[2-(1-methylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridin-7-yl]phenyl]methylcarbamoyl]-1,2,4-oxadiazol-5-yl]propan-2-yl]carbamate |
|---|---|
| PubChem CID | 157213156 |
| Molecular Formula | C51H52F2N18O6 |
| Molecular Weight | 1051.09 g/mol |
| Exact Mass | 1050.43 |
| IUPAC Name | 5-(2-aminopropan-2-yl)-N-[[2-fluoro-4-[2-(1-methylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridin-7-yl]phenyl]methyl]-1,2,4-oxadiazole-3-carboxamide;tert-butyl N-[2-[3-[[2-fluoro-4-[2-(1-methylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridin-7-yl]phenyl]methylcarbamoyl]-1,2,4-oxadiazol-5-yl]propan-2-yl]carbamate |
| SMILES | Cn1cc(-c2nc3nccc(-c4ccc(CNC(=O)c5noc(C(C)(C)N)n5)c(F)c4)c3[nH]2)cn1.Cn1cc(-c2nc3nccc(-c4ccc(CNC(=O)c5noc(C(C)(C)NC(=O)OC(C)(C)C)n5)c(F)c4)c3[nH]2)cn1 |
| InChI | InChI=1S/C28H30FN9O4.C23H22FN9O2/c1-27(2,3)41-26(40)36-28(4,5)25-35-23(37-42-25)24(39)31-12-16-8-7-15(11-19(16)29)18-9-10-30-22-20(18)33-21(34-22)17-13-32-38(6)14-17;1-23(2,25)22-31-20(32-35-22)21(34)27-9-13-5-4-12(8-16(13)24)15-6-7-26-19-17(15)29-18(30-19)14-10-28-33(3)11-14/h7-11,13-14H,12H2,1-6H3,(H,31,39)(H,36,40)(H,30,33,34);4-8,10-11H,9,25H2,1-3H3,(H,27,34)(H,26,29,30) |
| InChIKey | ASCRMAWRVAJKES-UHFFFAOYSA-N |
| XLogP | 6.91 |
| TPSA | 319.17 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 19 |
| Rotatable Bonds | 13 |
| Heavy Atoms | 77 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1051.09 |
| LogP ≤ 5 | 6.91 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 19 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157213156 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.